Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/1/19 → … |
Funding
- Conquer Cancer Foundation: US$200,000.00
ASJC Scopus Subject Areas
- Oncology
A Phase II Study of the PARP Inhibitor Olaparib in Combination with the DNA Damaging Agent Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
- Ingham, Matthew (PI)
Project: Research project